BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 30327409)

  • 1. Biased antagonism of CXCR4 avoids antagonist tolerance.
    Hitchinson B; Eby JM; Gao X; Guite-Vinet F; Ziarek JJ; Abdelkarim H; Lee Y; Okamoto Y; Shikano S; Majetschak M; Heveker N; Volkman BF; Tarasova NI; Gaponenko V
    Sci Signal; 2018 Oct; 11(552):. PubMed ID: 30327409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCR4 Antagonists: A Screening Strategy for Identification of Functionally Selective Ligands.
    Castaldo C; Benicchi T; Otrocka M; Mori E; Pilli E; Ferruzzi P; Valensin S; Diamanti D; Fecke W; Varrone M; Porcari V
    J Biomol Screen; 2014 Jul; 19(6):859-69. PubMed ID: 24632660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Arrestin1 and β-Arrestin2 Are Required to Support the Activity of the CXCL12/HMGB1 Heterocomplex on CXCR4.
    D'Agostino G; Artinger M; Locati M; Perez L; Legler DF; Bianchi ME; Rüegg C; Thelen M; Marchese A; Rocchi MBL; Cecchinato V; Uguccioni M
    Front Immunol; 2020; 11():550824. PubMed ID: 33072091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Arrestin1 and Signal-transducing Adaptor Molecule 1 (STAM1) Cooperate to Promote Focal Adhesion Kinase Autophosphorylation and Chemotaxis via the Chemokine Receptor CXCR4.
    Alekhina O; Marchese A
    J Biol Chem; 2016 Dec; 291(50):26083-26097. PubMed ID: 27789711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the molecular pharmacology of AMD3100: a specific antagonist of the G-protein coupled chemokine receptor, CXCR4.
    Fricker SP; Anastassov V; Cox J; Darkes MC; Grujic O; Idzan SR; Labrecque J; Lau G; Mosi RM; Nelson KL; Qin L; Santucci Z; Wong RS
    Biochem Pharmacol; 2006 Aug; 72(5):588-96. PubMed ID: 16815309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The peptidomimetic CXCR4 antagonist TC14012 recruits beta-arrestin to CXCR7: roles of receptor domains.
    Gravel S; Malouf C; Boulais PE; Berchiche YA; Oishi S; Fujii N; Leduc R; Sinnett D; Heveker N
    J Biol Chem; 2010 Dec; 285(49):37939-43. PubMed ID: 20956518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4.
    Hatse S; Princen K; Bridger G; De Clercq E; Schols D
    FEBS Lett; 2002 Sep; 527(1-3):255-62. PubMed ID: 12220670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands.
    Zabel BA; Wang Y; Lewén S; Berahovich RD; Penfold ME; Zhang P; Powers J; Summers BC; Miao Z; Zhao B; Jalili A; Janowska-Wieczorek A; Jaen JC; Schall TJ
    J Immunol; 2009 Sep; 183(5):3204-11. PubMed ID: 19641136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional and structural consequences of chemokine (C-X-C motif) receptor 4 activation with cognate and non-cognate agonists.
    Eby JM; Abdelkarim H; Albee LJ; Tripathi A; Gao X; Volkman BF; Gaponenko V; Majetschak M
    Mol Cell Biochem; 2017 Oct; 434(1-2):143-151. PubMed ID: 28455789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of AMD3465: a small molecule antagonist of the chemokine receptor CXCR4.
    Bodart V; Anastassov V; Darkes MC; Idzan SR; Labrecque J; Lau G; Mosi RM; Neff KS; Nelson KL; Ruzek MC; Patel K; Santucci Z; Scarborough R; Wong RS; Bridger GJ; Macfarland RT; Fricker SP
    Biochem Pharmacol; 2009 Oct; 78(8):993-1000. PubMed ID: 19540208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-Arrestin1 and distinct CXCR4 structures are required for stromal derived factor-1 to downregulate CXCR4 cell-surface levels in neuroblastoma.
    Clift IC; Bamidele AO; Rodriguez-Ramirez C; Kremer KN; Hedin KE
    Mol Pharmacol; 2014 Apr; 85(4):542-52. PubMed ID: 24452472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for chemokine recognition by a G protein-coupled receptor and implications for receptor activation.
    Ziarek JJ; Kleist AB; London N; Raveh B; Montpas N; Bonneterre J; St-Onge G; DiCosmo-Ponticello CJ; Koplinski CA; Roy I; Stephens B; Thelen S; Veldkamp CT; Coffman FD; Cohen MC; Dwinell MB; Thelen M; Peterson FC; Heveker N; Volkman BF
    Sci Signal; 2017 Mar; 10(471):. PubMed ID: 28325822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging CXCL12-CXCR4 signaling in ovarian cancer therapy.
    Salomonnson E; Stacer AC; Ehrlich A; Luker KE; Luker GD
    PLoS One; 2013; 8(1):e51500. PubMed ID: 23372646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial agonist activity of α1-adrenergic receptor antagonists for chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3.
    Gao X; Abdelkarim H; Albee LJ; Volkman BF; Gaponenko V; Majetschak M
    PLoS One; 2018; 13(9):e0204041. PubMed ID: 30248140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMD3100 is a CXCR7 ligand with allosteric agonist properties.
    Kalatskaya I; Berchiche YA; Gravel S; Limberg BJ; Rosenbaum JS; Heveker N
    Mol Pharmacol; 2009 May; 75(5):1240-7. PubMed ID: 19255243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist.
    Princen K; Hatse S; Vermeire K; Aquaro S; De Clercq E; Gerlach LO; Rosenkilde M; Schwartz TW; Skerlj R; Bridger G; Schols D
    J Virol; 2004 Dec; 78(23):12996-3006. PubMed ID: 15542651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural nitration of CXCL12 reduces its signaling capacity and chemotactic activity in vitro and abrogates intra-articular lymphocyte recruitment in vivo.
    Janssens R; Mortier A; Boff D; Vanheule V; Gouwy M; Franck C; Larsen O; Rosenkilde MM; Van Damme J; Amaral FA; Teixeira MM; Struyf S; Proost P
    Oncotarget; 2016 Sep; 7(38):62439-62459. PubMed ID: 27566567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consequences of ChemR23 heteromerization with the chemokine receptors CXCR4 and CCR7.
    de Poorter C; Baertsoen K; Lannoy V; Parmentier M; Springael JY
    PLoS One; 2013; 8(2):e58075. PubMed ID: 23469143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergy between coproduced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated events.
    Gouwy M; Struyf S; Noppen S; Schutyser E; Springael JY; Parmentier M; Proost P; Van Damme J
    Mol Pharmacol; 2008 Aug; 74(2):485-95. PubMed ID: 18469140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of tyrosine phosphorylation in ligand-independent sequestration of CXCR4 in human primary monocytes-macrophages.
    Wang J; Guan E; Roderiquez G; Calvert V; Alvarez R; Norcross MA
    J Biol Chem; 2001 Dec; 276(52):49236-43. PubMed ID: 11668182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.